Successful Retreatment Using Pembrolizumab for Non-Small Cell Lung Cancer After Severe Immune-Related Hepatitis: A Case Report
Clinical Lung Cancer - United States
doi 10.1016/j.cllc.2019.02.004
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
Elsevier BV